Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksNEULANDLAB
resources
NEULANDLAB

Neuland Laboratories Ltd.

NSE: NEULANDLAB
BSE: 524558
Sector: Healthcare
Industry: Pharmaceuticals
23,995.00+1040.0 (+4.53%)
8 Sep, 12:00 AM

Annual Reports and Financial Documents

Neuland Laboratories Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Neuland Laboratories Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. General7 Sept 2026
    Disclosure Under Regulation 30 Of SEBI Listing Regulations
    Disclosure under Regulation 30 of SEBI Listing Regulations
  2. Credit Rating25 Aug 2026
    Announcement under Regulation 30 (LODR)-Credit Rating
    Announcement under Regulation 30 (LODR) - Credit Rating
  3. Newspaper Publication23 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copy of Newspaper Publication
  4. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201117 Aug 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Malabar India Fund Ltd
  5. General14 Aug 2026
    Intimation Regarding Completion Of US FDA Inspection
    Intimation regarding completion of US FDA Inspection
  6. Analyst / Investor Meet7 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation about Schedule of Analyst / Institutional Investor Meeting on August 12, 2026
  7. Newspaper Publication6 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copy of Newspaper Publication
  8. Analyst / Investor Meet5 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio Recording of the Earnings call conducted on August 5, 2026
  9. General5 Aug 2026
    Disclosure Under Regulation 30 Of SEBI Listing Regulations
    Disclosure under Regulation 30 of SEBI Listing Regulations - Enhancement of manufacturing capacity
  10. General5 Aug 2026
    Disclosure Under Regulation 30 Of SEBI Listing Regulations
    Disclosure under Regulation 30 of SEBI Listing Regulations - Execution of deed of Corporate Guarantee
  11. Press Release / Media Release5 Aug 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release on the Financial Results of the Company for the quarter ended June 30, 2026
  12. Outcome of Board Meeting5 Aug 2026
    Board Meeting Outcome for Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026
    Unaudited Financial Results of the Company for the quarter ended June 30, 2026
  13. AGM4 Aug 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Voting Results, Scrutinizer Report and proceedings of 42nd Annual General Meeting held on August 4, 2026
  14. AGM4 Aug 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Voting Results, Scrutinizer Report and proceeding of 42nd Annual General Meeting held on August 4, 2026
  15. General31 Jul 2026
    Intimation Under Regulation 30 Of SEBI Listing Regulations
    Intimation under Regulation 30 of SEBI Listing Regulations
  16. Analyst / Investor Meet28 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Q1FY27 Earnings Call Intimation
  17. Board Meeting20 Jul 2026
    Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026
    Neuland Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve the unaudited financial ....
  18. Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate20 Jul 2026
    Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
    Intimation of Loss of Share Certificate(s)
  19. Credit Rating13 Jul 2026
    Announcement under Regulation 30 (LODR)-Credit Rating
    Announcement under Regulation 30 (LODR) - Credit Rating
  20. Newspaper Publication10 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication regarding dispatch of notice of 42nd Annual General Meeting and Integrated Annual Report for FY 2025-26

Frequently Asked Questions

Where can I download the annual report of Neuland Laboratories Ltd.?
Annual reports of Neuland Laboratories Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Neuland Laboratories Ltd.?
Quarterly earnings results and presentations of Neuland Laboratories Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Neuland Laboratories Ltd. publish earnings call transcripts?
Earnings call transcripts of Neuland Laboratories Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Neuland Laboratories Ltd.?
Investor presentations and annual day presentations of Neuland Laboratories Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Neuland Laboratories Ltd.?
Corporate announcements and regulatory filings of Neuland Laboratories Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Neuland Laboratories Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Neuland Laboratories Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Neuland Laboratories Ltd.?
The ISIN (International Securities Identification Number) of Neuland Laboratories Ltd. is INE794A01010. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Neuland Laboratories Ltd. listed?
Neuland Laboratories Ltd. is listed on NSE and BSE. The NSE symbol is NEULANDLAB and the BSE code is -.
Where can I find the shareholding pattern of Neuland Laboratories Ltd.?
The quarterly shareholding pattern of Neuland Laboratories Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Neuland Laboratories Ltd. on Sharpely?
Share price data for Neuland Laboratories Ltd. is updated as of 8 Sep 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.